INTERNATIONAL PATENT: NATIONAL UNIVERSITY OF SINGAPORE FILES APPLICATION FOR "GUIDING AND AUGMENTING NK CELL-BASED THERAPIES IN HIGH HLA-E EXPRESSING HUMAN CANCERS SUCH AS LEUKAEMIA"

GENEVA, March 18 -- NATIONAL UNIVERSITY OF SINGAPORE (21 Lower Kent Ridge Road,Singapore 119077) filed a patent application (PCT/SG2025/050587) for "GUIDING AND AUGMENTING NK CELL-BASED THERAPIES IN HIGH HLA-E EXPRESSING HUMAN CANCERS SUCH AS LEUKAEMIA" on Sep 05, 2025. With publication no. WO/2026/054717, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KRISHNAN, Vaidehi (c/o Duke-NUS Medical School8 College RoadSingapore 169857), ONG, Sin Tiong (c/o Duke-NUS Medical School8 College RoadSingapore 169857), YU, Mengge (c/o ...